Expert Consensus on Molecular Tumor Boards in Taiwan: Joint Position Paper by the Taiwan Oncology Society and the Taiwan Society of Pathology
Background: The Taiwan Oncology Society (TOS) and the Taiwan Society of Pathology (TSP) have collaborated to present a joint position paper on the molecular tumor boards (MTBs) within the medical institutions of Taiwan. Materials and Methods: To raise awareness of MTBs among health-care professional...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-01-01
|
| Series: | Journal of Cancer Research and Practice |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ejcrp.eJCRP-D-23-00050 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832591022210678784 |
|---|---|
| author | Ming-Huang Chen Wan-Shan Li Bin-Chi Liao Chiao-En Wu Chien-Feng Li Chia-Hsun Hsieh Feng-Che Kuan Huey-En Tzeng Jen-Fan Hang Nai-Jung Chiang Tse-Ching Chen Tom Wei-Wu Chen John Wen-Cheng Chang Yao-Yu Hsieh Yen-Lin Chen Yi-Chen Yeh Yi-Hsin Liang Yu-Li Su Chiung-Ru Lai James Chih-Hsin Yang |
| author_facet | Ming-Huang Chen Wan-Shan Li Bin-Chi Liao Chiao-En Wu Chien-Feng Li Chia-Hsun Hsieh Feng-Che Kuan Huey-En Tzeng Jen-Fan Hang Nai-Jung Chiang Tse-Ching Chen Tom Wei-Wu Chen John Wen-Cheng Chang Yao-Yu Hsieh Yen-Lin Chen Yi-Chen Yeh Yi-Hsin Liang Yu-Li Su Chiung-Ru Lai James Chih-Hsin Yang |
| author_sort | Ming-Huang Chen |
| collection | DOAJ |
| description | Background:
The Taiwan Oncology Society (TOS) and the Taiwan Society of Pathology (TSP) have collaborated to present a joint position paper on the molecular tumor boards (MTBs) within the medical institutions of Taiwan.
Materials and Methods:
To raise awareness of MTBs among health-care professionals, policymakers, and the public, a total of 20 experts from TOS and TSP formulated a joint consensus statement through a voting process.
Results:
The joint statement proposes key recommendations: (1) MTB discussions encompass diverse molecular analyses including next-generation sequencing (NGS), RNA sequencing, whole-exon sequencing, and whole-genomic sequencing addressing relevant genomic changes, tumor mutation burden, microsatellite instability, and specific biomarkers for certain cancers. (2) MTB meetings should involve multidisciplinary participants who receive regular updates on NGS-related clinical trials. (3) Prioritize discussing cases with unique clinical needs, gene alterations lacking treatments, untreatable neoplasms, or oncogenes unresponsive to targeted therapies. (4) Base MTB discussions on comprehensive patient data, including genetics, pathology, timing of specimen collection, and NGS outcomes. (5) MTBs offer treatment recommendations: standard therapies, off-label use, clinical trials, genetic counseling, and multidisciplinary reviews. (6) MTB effectiveness can be gauged by member composition, case reviews, treatment suggestions, and patient outcomes. Encourage government incentives for MTB engagement.
Conclusion:
The primary aim of this initiative is to promote the advancement of precision oncology in Taiwan. |
| format | Article |
| id | doaj-art-445838d2968349c0869dce108cd349c3 |
| institution | Kabale University |
| issn | 2311-3006 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Cancer Research and Practice |
| spelling | doaj-art-445838d2968349c0869dce108cd349c32025-01-23T05:10:28ZengWolters Kluwer Medknow PublicationsJournal of Cancer Research and Practice2311-30062024-01-01111182710.4103/ejcrp.eJCRP-D-23-00050Expert Consensus on Molecular Tumor Boards in Taiwan: Joint Position Paper by the Taiwan Oncology Society and the Taiwan Society of PathologyMing-Huang ChenWan-Shan LiBin-Chi LiaoChiao-En WuChien-Feng LiChia-Hsun HsiehFeng-Che KuanHuey-En TzengJen-Fan HangNai-Jung ChiangTse-Ching ChenTom Wei-Wu ChenJohn Wen-Cheng ChangYao-Yu HsiehYen-Lin ChenYi-Chen YehYi-Hsin LiangYu-Li SuChiung-Ru LaiJames Chih-Hsin YangBackground: The Taiwan Oncology Society (TOS) and the Taiwan Society of Pathology (TSP) have collaborated to present a joint position paper on the molecular tumor boards (MTBs) within the medical institutions of Taiwan. Materials and Methods: To raise awareness of MTBs among health-care professionals, policymakers, and the public, a total of 20 experts from TOS and TSP formulated a joint consensus statement through a voting process. Results: The joint statement proposes key recommendations: (1) MTB discussions encompass diverse molecular analyses including next-generation sequencing (NGS), RNA sequencing, whole-exon sequencing, and whole-genomic sequencing addressing relevant genomic changes, tumor mutation burden, microsatellite instability, and specific biomarkers for certain cancers. (2) MTB meetings should involve multidisciplinary participants who receive regular updates on NGS-related clinical trials. (3) Prioritize discussing cases with unique clinical needs, gene alterations lacking treatments, untreatable neoplasms, or oncogenes unresponsive to targeted therapies. (4) Base MTB discussions on comprehensive patient data, including genetics, pathology, timing of specimen collection, and NGS outcomes. (5) MTBs offer treatment recommendations: standard therapies, off-label use, clinical trials, genetic counseling, and multidisciplinary reviews. (6) MTB effectiveness can be gauged by member composition, case reviews, treatment suggestions, and patient outcomes. Encourage government incentives for MTB engagement. Conclusion: The primary aim of this initiative is to promote the advancement of precision oncology in Taiwan.https://journals.lww.com/10.4103/ejcrp.eJCRP-D-23-00050molecular tumor boardnext-generation sequencingtaiwan oncology societytaiwan society of pathology |
| spellingShingle | Ming-Huang Chen Wan-Shan Li Bin-Chi Liao Chiao-En Wu Chien-Feng Li Chia-Hsun Hsieh Feng-Che Kuan Huey-En Tzeng Jen-Fan Hang Nai-Jung Chiang Tse-Ching Chen Tom Wei-Wu Chen John Wen-Cheng Chang Yao-Yu Hsieh Yen-Lin Chen Yi-Chen Yeh Yi-Hsin Liang Yu-Li Su Chiung-Ru Lai James Chih-Hsin Yang Expert Consensus on Molecular Tumor Boards in Taiwan: Joint Position Paper by the Taiwan Oncology Society and the Taiwan Society of Pathology Journal of Cancer Research and Practice molecular tumor board next-generation sequencing taiwan oncology society taiwan society of pathology |
| title | Expert Consensus on Molecular Tumor Boards in Taiwan: Joint Position Paper by the Taiwan Oncology Society and the Taiwan Society of Pathology |
| title_full | Expert Consensus on Molecular Tumor Boards in Taiwan: Joint Position Paper by the Taiwan Oncology Society and the Taiwan Society of Pathology |
| title_fullStr | Expert Consensus on Molecular Tumor Boards in Taiwan: Joint Position Paper by the Taiwan Oncology Society and the Taiwan Society of Pathology |
| title_full_unstemmed | Expert Consensus on Molecular Tumor Boards in Taiwan: Joint Position Paper by the Taiwan Oncology Society and the Taiwan Society of Pathology |
| title_short | Expert Consensus on Molecular Tumor Boards in Taiwan: Joint Position Paper by the Taiwan Oncology Society and the Taiwan Society of Pathology |
| title_sort | expert consensus on molecular tumor boards in taiwan joint position paper by the taiwan oncology society and the taiwan society of pathology |
| topic | molecular tumor board next-generation sequencing taiwan oncology society taiwan society of pathology |
| url | https://journals.lww.com/10.4103/ejcrp.eJCRP-D-23-00050 |
| work_keys_str_mv | AT minghuangchen expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT wanshanli expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT binchiliao expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT chiaoenwu expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT chienfengli expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT chiahsunhsieh expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT fengchekuan expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT hueyentzeng expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT jenfanhang expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT naijungchiang expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT tsechingchen expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT tomweiwuchen expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT johnwenchengchang expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT yaoyuhsieh expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT yenlinchen expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT yichenyeh expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT yihsinliang expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT yulisu expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT chiungrulai expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology AT jameschihhsinyang expertconsensusonmoleculartumorboardsintaiwanjointpositionpaperbythetaiwanoncologysocietyandthetaiwansocietyofpathology |